Sec. 802. PRIORITY REVIEW

131 words·~1 min read·/statute-compilations/comps-9932/sec-802

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 802 PRIORITY REVIEW ###

(a)Amendment Chapter V (21 U.S.C. 351 et seq.) is amended by inserting after section 524 the following: > > ## “SEC. 524A PRIORITY REVIEW FOR QUALIFIED INFECTIOUS DISEASE PRODUCTS > > **[**[21 U.S.C. 360n-1](/us/usc/t21/s360n-1)**]** > > “If the Secretary designates a drug under section 505E(d) as a qualified infectious disease product, then the Secretary shall give priority review to any application submitted for approval for such drug under section 505(b).” > . ###

(b)Application **[**[21 U.S.C. 360n-1 note](/us/usc/t21/s360n-1)**]** Section 524A of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a), applies only with respect to an application that is submitted under section 505(b) of such Act (21 U.S.C. 355(b)) on or after the date of the enactment of this Act.

Connectionstraces to 3

Traces to 3 documents

U.S. Code

Citation graph

cites case law

Sec. 802

PRIORITY REVIEW

U.S.C.§ 351

U.S.C.§ 360n–1

U.S.C.§ 355

Cites 3Cited by 0 across 0 sources